## Clinical Diagnosis The patient presents with the classic triad of **non-proliferative diabetic retinopathy with clinically significant macular edema (CSME)**: ### Key Findings Analysis | Finding | Significance | |---------|-------------| | Dot-blot hemorrhages | Indicate capillary rupture; hallmark of NPDR | | Hard exudates in circinate pattern | Lipid exudation; when around macula = CSME | | Microaneurysms | Early vascular change in NPDR | | Visual acuity 6/9 (relatively preserved) | Suggests macular edema without foveal center involvement (yet) | | Absence of neovascularization | Rules out PDR | **Key Point:** CSME is defined as: - Hard exudates within 500 µm of the foveal center, OR - Retinal thickening within 500 µm of the fovea, OR - Hard exudates and thickening involving an area ≥ 1 disc diameter within 1 disc diameter of the fovea The circinate pattern of hard exudates around the macula is pathognomonic for CSME and indicates leakage from damaged capillaries. ### Why This Stage? **High-Yield:** NPDR with CSME is the most common cause of vision loss in diabetic retinopathy before proliferative disease develops. The presence of microaneurysms, hemorrhages, and hard exudates without neovascularization confirms NPDR; the circinate exudate pattern confirms macular involvement. **Clinical Pearl:** Even with visual acuity of 6/9, CSME requires urgent treatment (laser photocoagulation or anti-VEGF agents) because the exudates are actively damaging the macula and vision will deteriorate without intervention. ### Management Implications 1. Optical coherence tomography (OCT) to quantify macular thickness 2. Urgent referral for laser photocoagulation or intravitreal anti-VEGF injection 3. Tight glycemic control (target HbA1c < 7%) and blood pressure management (< 140/90) **Mnemonic:** **CSME** = **C**ircinate exudates, **S**welling (thickening), **M**acula, **E**xudation [cite:Yanoff & Duker 6e Ch 6] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.